Gestational diabetes augments group B Streptococcus infection by disrupting maternal immunity and the vaginal microbiota

妊娠期糖尿病会破坏母体免疫力和阴道微生物群,从而加剧B族链球菌感染。

阅读:10
作者:Vicki Mercado-Evans ,Marlyd E Mejia ,Jacob J Zulk ,Samantha Ottinger ,Zainab A Hameed ,Camille Serchejian ,Madelynn G Marunde ,Clare M Robertson ,Mallory B Ballard ,Simone H Ruano ,Natalia Korotkova ,Anthony R Flores ,Kathleen A Pennington ,Kathryn A Patras

Abstract

Group B Streptococcus (GBS) is a pervasive perinatal pathogen, yet factors driving GBS dissemination in utero are poorly defined. Gestational diabetes mellitus (GDM), a complication marked by dysregulated immunity and maternal microbial dysbiosis, increases risk for GBS perinatal disease. Using a murine GDM model of GBS colonization and perinatal transmission, we find that GDM mice display greater GBS in utero dissemination and subsequently worse neonatal outcomes. Dual-RNA sequencing reveals differential GBS adaptation to the GDM reproductive tract, including a putative glycosyltransferase (yfhO), and altered host responses. GDM immune disruptions include reduced uterine natural killer cell activation, impaired recruitment to placentae, and altered maternofetal cytokines. Lastly, we observe distinct vaginal microbial taxa associated with GDM status and GBS invasive disease status. Here, we show a model of GBS dissemination in GDM hosts that recapitulates several clinical aspects and identifies multiple host and bacterial drivers of GBS perinatal disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。